Advanced Biomed is trading at $1.87, down 10.95% as of November 5, 2026, with broad market weakness and biotech-sector losses the likeliest explanation.
- Major U.S. indexes are sharply lower, with pressure on growth stocks and a substantial biotech decline.
- No confirmed company-specific announcement explains the move; recent company headlines do not establish a new catalyst for this session.